Sustained Response

Sustained* immune response and short duration of treatment among patients with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer1

6 month duration

6 months (26 Weeks)

  • *Observed out to 26 weeks in the pivotal study (the last time point measured)1
Short duration of treatment
A Sample PROVENGE Schedule

Approximately 1 month

  • PROVENGE is administered in three 1-hour infusions, each preceded by a standard leukapheresis procedure (a standard cell-collection procedure performed at a blood center)
  • The dosing interval ranged from 1 to 15 weeks in controlled clinical trials
  • Apheresis and PROVENGE infusions will be scheduled 2 to 3 days apart and can start on various days of the week
  • Prior to the first leukapheresis procedure, a venous assessment must be done by the prescribing practitioner


  1. Provenge [prescribing information]. Seattle, WA: Dendreon Corporation; 2014.